Online inquiry

IVTScrip™ mRNA-Human ABHD17B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK10567MR)

This product GTTS-WK10567MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABHD17B protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001025780.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51104
UniProt ID Q5VST6
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD17B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK10567MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK24382MR IVTScrip™ mRNA-Human ARHGAP12, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ARHGAP12
GTTS-WK21395MR IVTScrip™ mRNA-Human ALDH1A2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALDH1A2
GTTS-WK22562MR IVTScrip™ mRNA-Human AREL1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA AREL1
GTTS-WK10714MR IVTScrip™ mRNA-Human ADARB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADARB2
GTTS-WK24674MR IVTScrip™ mRNA-Human ARFRP1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARFRP1
GTTS-WK18036MR IVTScrip™ mRNA-Human AIMP2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA AIMP2
GTTS-WK13341MR IVTScrip™ mRNA-Human ACPP, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACPP
GTTS-WK9572MR IVTScrip™ mRNA-Human ADSS, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADSS
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →